T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-06-22	1,980.00 ₩	-4.35%	265,902
26-06-19	2,070.00 ₩	-3.72%	259,352
26-06-18	2,150.00 ₩	-4.23%	171,725
26-06-17	2,245.00 ₩	+2.28%	354,433
26-06-16	2,195.00 ₩	+4.52%	122,565

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Korea S.E. Other stock markets 2026-06-22			5-day change	1st Jan Change
1,980.00 ^KRW	-4.35%		-8.55%	-49.36%

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	94.38B 61.53M 53.89M 49.74M 46.53M 87.11M 5.83B 87.86M 592M 230M 2.86B 231M 226M 9.97B	P/E 2024	-12.2x	P/E 2025	-3.58x
Enterprise Value	116B 75.68M 66.28M 61.17M 57.23M 107M 7.17B 108M 728M 283M 3.52B 284M 278M 12.26B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	82.77%	Yield 2024 *	-	Yield 2025	-

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
24-08-04	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
24-07-22	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
24-07-03	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
24-06-24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
23-12-21	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-12-13	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-10-18	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
23-08-03	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
23-07-25	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
23-05-14	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
21-09-20	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	-4.35%
1 week	-8.55%
Current month	-2.94%
1 month	-10.61%
3 months	-34.87%
6 months	-51.59%
Current year	-49.36%

T&R Biofab Co., Ltd. Stock

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news : T&R Biofab Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	1,951	2,395
1 month	1,951	2,415
Current year	1,951	4,800
1 year	1,127	4,925
3 years	1,127	11,575
5 years	1,127	37,916.67
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Jin-Hyung Shin CTO	Chief Tech/Sci/R&D Officer	41	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
25-03-05	Eun-kyung Cho	Others		15,492	0.0719%
25-03-05	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
25-02-25	Won-Soo Yoon	Buy	Chief Executive Officer	7,500	0.0348%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	-4.35%	-8.55%	-52.86%	-81.68%	64.45M
STRYKER CORPORATION	-1.01%	-2.41%	-18.87%	+2.39%	118B
SMITH & NEPHEW PLC	-1.02%	-1.72%	+3.15%	-9.80%	12.63B
GLAUKOS CORPORATION	+0.39%	+3.45%	+30.99%	+102.11%	7.67B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.89%	-2.23%	-46.25%	-70.77%	4.07B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.23%	-0.95%	+18.00%	+36.84%	2.55B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-2.67%	-3.88%	-16.52%	-15.40%	1.77B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.78%	-4.81%	+3.45%	-21.06%	1.59B
L&C BIO CO.,LTD	+4.14%	+14.43%	+201.37%	+162.69%	1.49B
Average	-0.63%	-0.18%	+13.61%	+11.70%	16.65B
Weighted average by Cap.	-0.86%	+0.74%	-12.14%	+6.17%

	2024	2025
Net sales	4.87B 3.18M 2.78M 2.57M 2.4M 4.5M 301M 4.54M 30.57M 11.86M 148M 11.93M 11.67M 515M	26.97B 17.58M 15.4M 14.21M 13.29M 24.89M 1.66B 25.11M 169M 65.64M 817M 66.02M 64.59M 2.85B
Net income	-7.68B -5.01M -4.38M -4.05M -3.79M -7.09M -474M -7.15M -48.17M -18.69M -233M -18.8M -18.39M -811M	-34.94B -22.78M -19.95M -18.42M -17.23M -32.25M -2.16B -32.53M -219M -85.05M -1.06B -85.54M -83.69M -3.69B
Net Debt	28.78B 18.76M 16.43M 15.17M 14.19M 26.56M 1.78B 26.79M 181M 70.05M 872M 70.45M 68.93M 3.04B	21.7B 14.15M 12.39M 11.44M 10.7M 20.03M 1.34B 20.2M 136M 52.82M 658M 53.13M 51.98M 2.29B